VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
RYTM
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
RYTMRhythm Pharmaceuticals, Inc.
$111.68$7.7B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksRYTMQuarterly Financials

Rhythm Pharmaceuticals, Inc. (RYTM) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Rhythm Pharmaceuticals, Inc. (RYTM) quarterly income statement — complete revenue, gross profit & net income history

RYTM Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue60.11M57.25M51.3M48.5M32.7M41.83M33.25M29.08M25.97M24.23M22.5M19.22M11.47M8.79M4.28M9.07M1.5M1.82M1.03M274K
Revenue Growth %83.81%36.87%54.28%66.8%25.94%72.61%47.76%51.28%126.41%175.7%425.3%112.01%665.62%383.76%316.73%3208.76%4180%---
Cost of Goods Sold7.16M4.8M5.5M5.54M3.65M3.79M3.83M2.95M2.81M3.23M2.41M2.24M1.42M1.03M497K378K230K236K222K137K
COGS % of Revenue11.91%8.39%10.72%11.43%11.15%9.05%11.51%10.13%10.81%13.34%10.72%11.63%12.39%11.7%11.6%4.17%15.35%12.99%21.6%50%
Gross Profit52.95M52.45M45.8M42.96M29.06M38.04M29.42M26.13M23.16M21M20.09M16.98M10.05M7.76M3.79M8.69M1.27M1.58M806K137K
Gross Margin %88.09%91.61%89.28%88.57%88.85%90.95%88.49%89.87%89.19%86.66%89.28%88.37%87.61%88.3%88.4%95.83%84.65%87.01%78.4%50%
Gross Profit Growth %82.25%37.87%55.66%64.4%25.46%81.15%46.44%53.85%130.49%170.56%430.55%95.5%692.43%390.96%369.85%6241.61%3990.32%---
Operating Expenses105.32M99.51M98.45M88.25M76.06M79.3M73.31M66.61M163.05M62.27M64.05M63.59M62.58M49.87M43.05M53.78M53.96M52.57M45.05M40.57M
OpEx % of Revenue175.2%173.81%191.92%181.96%232.57%189.57%220.47%229.07%627.9%256.94%284.59%330.83%545.64%567.29%1005%593.25%3602.07%2893.23%4381.91%14806.2%
Selling, General & Admin63.59M57.48M52.43M45.95M39.09M38.13M35.38M36.41M34.38M32.37M30.48M30.05M24.63M26.32M21.94M22.33M21.45M21M17.51M15.46M
SG&A % of Revenue105.79%100.4%102.2%94.73%119.52%91.15%106.39%125.23%132.41%133.59%135.42%156.32%214.79%299.4%512.09%246.28%1431.84%1155.59%1703.02%5644.16%
Research & Development41.73M42.03M46.03M42.31M36.97M41.17M37.93M30.02M128.47M29.89M33.57M33.54M37.95M23.55M21.12M31.46M32.51M31.57M27.54M25.1M
R&D % of Revenue69.41%73.42%89.72%87.23%113.05%98.42%114.07%103.23%494.76%123.35%149.17%174.51%330.85%267.9%492.9%346.97%2170.23%1737.7%2678.89%9162.04%
Other Operating Expenses00000000000000000000
Operating Income-52.36M-47.06M-52.65M-45.3M-47M-41.26M-43.88M-40.48M-139.89M-41.27M-43.95M-46.6M-52.53M-42.1M-39.27M-45.1M-52.69M-50.99M-44.24M-40.43M
Operating Margin %-87.11%-82.2%-102.64%-93.39%-143.73%-98.63%-131.98%-139.2%-538.71%-170.28%-195.31%-242.46%-458.03%-478.99%-916.6%-497.42%-3517.42%-2806.22%-4303.5%-14756.2%
Operating Income Growth %-11.4%-14.08%-19.98%-11.9%66.4%0.02%0.15%13.14%-166.29%1.99%-11.93%-3.34%0.3%17.43%11.24%-11.54%-53.18%-45.38%-29.04%-26.67%
EBITDA-52.36M-46.79M-52.35M-44.92M-46.62M-40.87M-43.5M-40.09M-139.48M-40.85M-43.51M-46.16M-52.07M-41.66M-38.83M-44.66M-52.34M-50.66M-43.92M-40.12M
EBITDA Margin %-87.11%-81.73%-102.05%-92.61%-142.55%-97.71%-130.82%-137.86%-537.15%-168.56%-193.35%-240.16%-454.04%-473.96%-906.28%-492.59%-3494.06%-2788.33%-4272.86%-14640.51%
EBITDA Growth %-12.31%-14.48%-20.34%-12.05%66.58%-0.06%0.03%13.16%-167.85%1.95%-12.07%-3.37%0.51%17.77%11.61%-11.32%-53.06%-45.19%-28.77%-26.37%
D&A (Non-Cash Add-back)0272K304K379K383K383K385K390K405K417K442K442K457K442K442K438K350K325K315K317K
EBIT0-42.92M-48.05M-40.48M-44.01M-37.94M-38.74M-27.18M-136.32M-36.89M-40.65M-43.4M-49.12M-39.48M-38.72M-44.95M-52.69M-50.99M-44.1M-40.43M
Net Interest Income0-530K-415K-2.58M-1.77M-1.93M-1.19M-506K-1.71M-731K317K-82K379K30K-1.22M228K160K134K138K21K
Interest Income3.55M4.08M4.33M3.24M3.64M3.52M4.05M4.1M3.05M3.82M3.47M3.22M3.44M3.04M920K274K160K134K138K21K
Interest Expense-4.58M4.62M4.74M5.82M5.41M5.45M5.24M4.6M4.75M4.55M3.15M3.3M3.06M3.01M2.14M46K0000
Other Income/Expense-2.73M-473K-140K-999K-2.41M-2.13M-100K8.7M-1.19M-172K158K-99K352K-390K-1.59M95K-73K134K138K21K
Pretax Income-55.09M-47.54M-52.79M-46.3M-49.42M-43.38M-43.98M-31.78M-141.07M-41.44M-43.8M-46.7M-52.18M-42.49M-40.86M-45M-52.76M-50.85M-44.1M-40.41M
Pretax Margin %-91.65%-83.03%-102.91%-95.45%-151.11%-103.71%-132.28%-109.3%-543.27%-170.99%-194.61%-242.98%-454.96%-483.42%-953.8%-496.37%-3522.3%-2798.84%-4290.08%-14748.54%
Income Tax545K-31K111K337K80K-90K-344K479K300K196K368K000000-7.99M-8.99M-5.02M
Effective Tax Rate %-0.99%0.07%-0.21%-0.73%-0.16%0.21%0.78%-1.51%-0.21%-0.47%-0.84%0%0%0%0%0%0%15.71%20.4%12.43%
Net Income-56.74M-47.51M-52.9M-46.63M-49.5M-43.29M-43.64M-32.26M-141.37M-41.63M-44.16M-46.7M-52.18M-42.49M-40.86M-45M-52.76M-42.87M-35.11M-35.39M
Net Margin %-94.4%-82.97%-103.13%-96.14%-151.35%-103.5%-131.25%-110.95%-544.43%-171.8%-196.25%-242.98%-454.96%-483.42%-953.8%-496.37%-3522.3%-2359.16%-3415.08%-12915.69%
Net Income Growth %-14.64%-9.73%-21.23%-44.55%64.99%-3.98%1.18%30.92%-170.94%2.02%-8.08%-3.78%1.11%0.87%-16.39%-27.16%-220.6%-22.84%-3.81%-13.73%
Net Income (Continuing)-56.74M-47.51M-52.9M-46.63M-49.5M-43.29M-43.64M-32.26M-141.37M-41.63M-44.16M-46.7M-52.18M-42.49M-40.86M-45M-52.76M-42.87M-35.11M-35.39M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.83-0.73-0.82-0.75-0.81-0.72-0.71-0.53-2.35-0.70-0.76-0.82-0.91-0.75-0.83-0.89-1.05-0.85-0.70-0.70
EPS Growth %-2.47%-1.39%-15.49%-41.51%65.53%-2.86%6.58%35.37%-158.24%6.67%8.43%7.87%13.33%11.76%-18.57%-27.14%-216.67%-7.59%9.09%1.41%
EPS (Basic)-0.83-0.73-0.82-0.75-0.81-0.72-0.71-0.53-2.35-0.70-0.76-0.82-0.91-0.75-0.83-0.89-1.05-0.85-0.70-0.70
Diluted Shares Outstanding67.97M66.88M64.35M63.68M63.06M61.6M61.22M61.01M60.14M59.21M57.87M56.87M56.71M56.3M51.4M50.4M50.33M50.27M50.25M50.21M
Basic Shares Outstanding67.97M66.88M64.35M63.68M63.06M61.6M61.22M61.01M60.14M59.21M57.87M56.87M56.71M56.3M51.4M50.4M50.25M50.27M50.25M50.21M
Dividend Payout Ratio--------------------